P. John Schmid

Affiliations

  • at Design Therapeutics Inc. (DSGN), 2024-03-25
  • Director at Xeris Biopharma Holdings Inc. (XERS), 2024-03-15
  • Director at Helix Acquisition Corp. Ii (HLXB), 2024-02-09
  • Director at Anaptysbio Inc (ANAB), 2024-01-05
  • at Poseida Therapeutics Inc. (PSTX), 2023-06-16
  • Director at Xeris Pharmaceuticals Inc (XERS), 2021-10-05
  • Director at Neos Therapeutics Inc. (NEOS), 2021-03-19
  • Director at Helix Acquisition Corp (HLXA), 2020-10-20
  • Chief Financial Officer at Auspex Pharmaceuticals Inc. (ASPX), 2015-05-06
  • Chief Financial Officer at Trius Therapeutics Inc (TSRX), 2013-09-13
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DSGN $3.74 17,809 26,965 2024-03-25 Filing
DSGN $3.62 9,156 9,156 2024-03-22 Filing
XERS $2.16 4,500 Director 11,000 2024-03-14 Filing
XERS $1.51 6,500 Director 6,500 2023-11-16 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TSRX $6.00 1,800 Officer 107,639 2012-06-22 Filing
TSRX $5.04 500 Officer 104,439 2012-03-01 Filing
TSRX $5.63 500 Officer 104,939 2012-02-02 Filing
TSRX $7.28 700 Officer 105,439 2012-01-03 Filing
TSRX $7.50 700 Officer 106,139 2011-12-01 Filing